Editor’s Note: As the 340B program draws increased attention from researchers, policymakers and commentators, 340B Report has launched a new [...] …
Blog Posts
The Trump administration is expected to move oversight of the 340B program from its longtime home at HRSA to CMS, [...] …
Please Login or Become a Paid Subscriber to View this Content
A key hospital trade group accused drugmakers of holding 340B discounts “hostage” and rewriting program rules to “line their pockets” [...] …
Please Login or Become a Paid Subscriber to View this Content
Six New York congressional Republicans called on CMS leaders this week to “seriously reconsider” a proposed federal outpatient payment rule [...] …
Please Login or Become a Paid Subscriber to View this Content
SPONSORED CONTENT
Covered entities participating in the 340B program continue to operate in an environment of increasing complexity and scrutiny. As regulatory expectations evolve, one area that has emerged as a critical point of vulnerability is referral
…
A Colorado federal judge on Tuesday dismissed a drug industry trade group’s lawsuit against the state’s 340B access law—one day [...] …
Please Login or Become a Paid Subscriber to View this Content
As 340B litigation heats up in the states following the enactment of new contract pharmacy access and claims data restriction [...] …
Please Login or Become a Paid Subscriber to View this Content
Pharmaceutical manufacturers AbbVie and Organon recently announced new state exemptions to their 340B contract pharmacy restrictions following legal developments in [...] …
Please Login or Become a Paid Subscriber to View this Content
Q: What is the primary problem 340BCheck solves?
Covered entities (CEs) face growing 340B compliance risk but lack the tools to keep pace with…
Read More »
HRSA has contacted certain 340B providers about agreements with their contract pharmacies that could be released to French drugmaker Sanofi [...] …
